Volume-sensitive organic osmolyte/anion channels in cancer: Novel approaches to studying channel modulation employing proteomics technologies

Annals of the New York Academy of Sciences

Volumn 1028, Issue , 2004, Pages 38-55

  Davies, Andrew R L ^a   Belsey, Mark J ^a   Kozlowski, Roland Z ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

cancer; Protein protein interactions; Proteomics; Volume sensitive organic osmolyte anion channel; VSOAC

Indexed keywords

ANION CHANNEL; ANTINEOPLASTIC AGENT; ION CHANNEL; ION TRANSPORT AFFECTING AGENT; UNCLASSIFIED DRUG; VOLUME SENSITIVE ORGANIC OSMOLYTE ANION CHANNEL BLOCKING AGENT;

ANGIOGENESIS; CANCER; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CHANNEL GATING; CONFERENCE PAPER; DRUG SCREENING; ELECTROPHYSIOLOGY; HUMAN; NONHUMAN; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; PROTEOMICS; VOLUME SENSITIVE ORGANIC OSMOLYTE ANION CHANNEL;

EID: 14944338732     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1322.004     Document Type: Conference Paper

References (97)

1. NILIUS, B., J. EGGERMONT & G. DROOGMANS. 2000. The endothelial volume-regulated anion channel, VRAC. Cell. Physiol. Biochem. 10: 313-320.
2. EMMA, F., M. MCMANUS & K. STRANGE. 1997. Intracellular electrolytes regulate the volume set point of the organic osmolyte/anion channel VSOAC. Am. J. Physiol. 272: 1766-1775.
3. JACKSON, P.S., R. MORRISON & K. STRANGE. 1994. The volume-sensitive organic osmolyte-anion channel VSOAC is regulated by nonhydrolytic ATP binding Am. J. Physiol. 267: 1203-1209.
4. HUXTABLE, R.J. 1992. Physiological actions of taurine. Physiol. Rev. 72: 101-163.
5. JACKSON, P.S. & K. STRANGE. 1993. Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux. Am. J. Physiol. 265: 1489-1500.
6. BANDERALI, U. & G. ROY. 1992. Anion channels for amino acids in MDCK cells. Am. J. Physiol. 263: 1200-1207.
7. STUTZIN, A., R. TORRES, M. OPORTO, et al. 1999. Separate taurine and chloride efflux pathways activated during regulatory volume decrease. Am. J. Physiol. 277: 392-402.
8. SHEN, M.R., G. DROOGMANS, J. EGGERMONT, et al. 2000. Differential expression of volume-regulated anion channels during cell cycle progression of human cervical cancer cells. J. Physiol. 529: 385-394.
9. CHANG, C. & Z. WERB. 2001. The many faces of metalloproteases: cell growth, invasion, angiogenesis, and metastasis. Trends Cell Biol. 11: 37-43.
10. CHOU, C.Y., M.R. SHEN & S.N. WU. 1995. Volume-sensitive chloride channels associated with human cervical carcinogenesis. Cancer Res. 55: 6077-6083.
11. VOETS, T., L. WEI, P. DE SMET, et al. 1997. Downregulation of volume-activated C1-currents during muscle differentiation. Am. J. Physiol. 272: 667-674.
12. SHEN, M.R., C.Y. CHOU, M.L. WU & K.E. HUANG. 1998. Differential osmosensing signaling pathways and G-protein involvement in human cervical cells with different tumor potential. Cell. Signalling 10: 113-120.
13. WONDERLIN, W.F. & J.S. STROBL. 1996. Potassium channels, proliferation and G1 progression. J. Membr. Biol. 154: 91-107.
14. DOROSHENKO, P., V. SABANOV & N. DOROSHENKO. 2001. Cell cycle-related changes in regulatory volume decrease and volume-sensitive chloride conductance in mouse fibroblasts. J. Cell. Physiol. 187: 65-72.
15. LANG, F., G. L. BUSCH, M. RITTER, et al. 1998. Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 78: 247-306.
16. NILIUS, B. 2001. Chloride channels go cell cycling. J. Physiol. 532: 581.
17. NILIUS, B., J. EGGERMONT, T. VOETS & G. DROOGMANS. 1996. Volume-activated C1-channels. Gen. Pharmacol. 27: 1131-1140.
18. WONDERGEM, R., W. GONG, S.H. MONEN, et al. 2001. Blocking swelling-activated chloride current inhibits mouse liver cell proliferation. J. Physiol. 532: 661-672.
19. VOETS, T., G. SZUCS, G. DROOGMANS & B. NILIUS. 1995. Blockers of volume-activated C1-currents inhibit endothelial cell proliferation. Pflugers Arch. 431: 132-134.
20. - channels in macrovascular endothelial cells. Br. J. Pharmacol. 121: 547-555.
21. CHEN, L., L. WANG, L. ZHU, et al. 2002. Cell cycle-dependent expression of volume-activated chloride currents in nasopharyngeal carcinoma cells. Am. J. Physiol. 283: 1313-1323.
22. ULLRICH, N. & H. SONTHEIMER. 1997. Cell cycle-dependent expression of a glioma-specific chloride current: proposed link to cytoskeletal changes. Am. J. Physiol. 273: 1290-1297.
23. + transport in human cervical cancer cells: association with cell cycle progression. Pflugers Arch. 441: 787-795.
24. ALFIERI, R.R., A. CAVAZZONI, PG. PETRONINI, et al. 2002. Compatible osmolytes modulate the response of porcine endothelial cells to hypertonicity and protect them from apoptosis. J. Physiol. 540: 499-508.
25. MANOLOPOULOS, V. G., G. DROOGMANS & B. NILIUS. 1997. Hypotonicity and thrombin activate taurine efflux in BC3H1 and C2C12 myoblasts that is down regulated during differentiation. Biochem. Biophys. Res. Commun. 232: 74-79.
26. SCHWAB, A. 2001. Function and spatial distribution of ion channels and transporters in cell migration. Am. J. Physiol. 280: 739-747.
27. BELSEY, M.J., S.J. CULLIFORD, R.M. MORLEY, et al. 2003. Newly identified structurally disparate modulators of osmosensitive taurine efflux inhibit cell cycle progression. Eur. J. Pharmacol. 474: 185-193.
28. RANSOM, C.B., J.T. O'NEAL & H. SONTHEIMER. 2001. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J. Neurosci. 21: 7674-7683.
29. + ion channel blockers. J. Neurosci. 19: 5942-5954.
30. MANOLOPOULOS, V.G., S. LIEKENS, P. KOOLWIJK, et al. 2000. Inhibition of angiogenesis by blockers of volume-regulated anion channels. Gen. Pharmacol. 34: 107-116.
31. RANIERI, G. & G. GASPARINI. 2001. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy. Curr. Drug Targets Immune Endocr. Metabol. Disord. 1: 241-253.
32. NILIUS, B., J. EGGERMONT, T. VOETS, et al. 1997. Properties of volume-regulated anion channels in mammalian cells. Prog. Biophys. Mol. Biol. 68: 69-119.
33. JENTSCH, T.J., V. STEIN, F. WEINREICH & A.A. ZDEBIK. 2002. Molecular structure and physiological function of chloride channels. Physiol. Rev. 82: 503-568.
34. MULVANEY, A.W., C.I. SPENCER, S. CULLIFORD, et al. 2000. Cardiac chloride channels: physiology, pharmacology, and approaches for identifying novel modulators of activity. Drug Discov. Today 5: 492-505.
35. BROCHIERO, E., B. WALLENDORF, D. GAGNON, et al. 2002. Cloning of rabbit Kir6.1, SUR2A, and SUR2B: possible candidates for a renal K(ATP) channel. Am. J. Physiol. Renal Physiol. 282: 289-300.
36. DUTZLER, R., E.B. CAMPBELL, M. CADENE, et al. 2002. X-ray structure of a C1C chloride channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature 415: 287-294.
37. DUAN, D., C. WINTER, S. COWLEY, et al. 1997. Molecular identification of a volume-regulated chloride channel. Nature 390: 417-421.
38. WEYLANDT, K.H., M.A. VALVERDE, M. NOBLES, et al. 2001. Human C1C-3 is not the swelling-activated chloride channel involved in cell volume regulation. J. Biol. Chem. 276: 17461-17467.
39. STOBRAWA, S. M., T. BREIDERHOFF, S. TAKAMORI, et al. 2001. Disruption of C1C-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron 29: 185-196.
40. WANG, G.L., X.R. WANG, M.J. LIN, et al. 2002. Deficiency in C1C-3 chloride channels prevents rat aortic smooth muscle cell proliferation. Circ. Res. 91: 28-32.
41. HERMOSO, M., C.M. SATTERWHITE, Y.N. ANDRADE, et al. 2002. C1C-3 is a fundamental molecular component of volume-sensitive outwardly rectifying C1- channels and volume regulation in HeLa cells and Xenopus laevis oocytes. J. Biol. Chem. 277: 40066-40074.
42. GENTZSCH, M., L. CUI, A. MENGOS, et al. 2003. The PDZ-binding chloride channel C1C-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins. J. Biol. Chem. 278: 6440-6449.
43. OGURA, T., T. FURUKAWA, T. TOYOZAKI, et al. 2002. C1C-3B, a novel C1C-3 splicing variant that interacts with EBP50 and facilitates expression of CFTR-regulated ORCC. FASEB J. 16: 863-865.
44. COCA-PRADOS, M., J. SANCHEZ-TORRES, K. PETERSON-YANTORNO & M. M. CIVAN. 1996. Association of C1C-3 channel with C1- transport by human nonpigmented ciliary epithelial cells. J. Membr. Biol. 150: 197-208.
45. OKADA, Y. 1997. Volume expansion-sensing outward-rectifier C1- channel: fresh start to the molecular identity and volume sensor. Am. J. Physiol. 273: 755-789.
46. SHEN, M.R., C.Y. CHOU, K.F. HSU, et al. 1999. Modulation of volume-sensitive C1 - channels and cell volume by actin filaments and microtubules in human cervical cancer HT-3 cells. Acta Physiol. Scand. 167: 215-225.
47. TROUET, D., D. HERMANS, G. DROOGMANS, et al. 2001. Inhibition of volume-regulated anion channels by dominant-negative caveolin-1. Biochem. Biophys. Res. Commun. 284: 461-465.
48. TROUET, D., I. CARTON, D. HERMANS, et al. 2001. Inhibition of VRAC by c-Src tyrosine kinase targeted to caveolae is mediated by the Src homology domains. Am. J. Physiol. 281: 248-256.
49. TROUET, D., B. NILIUS, A. JACOBS, et al. 1999. Caveolin-1 modulates the activity of the volume-regulated chloride channel. J. Physiol. 520: 113-119.
50. PEDERSEN, S.F., K.H. BEISNER, C. HOUGAARD, et al. 2002. Rho family GTP binding proteins are involved in the regulatory volume decrease process in NIH3T3 mouse fibroblasts. J. Physiol. 541: 779-796.
51. CARTON, I., D. HERMANS & J. EGGERMONT. 2003. Hypotonicity induces membrane protrusions and actin remodeling via activation of small GTPases Rac and Cdc42 in Rat-1 fibroblasts. Am. J. Physiol. Cell Physiol. 285: 935-944.
52. SANCHEZ, O.R., H. PASANTES-MORALES, A. LAZARO & M. CEREIJIDO. 1991. Osmolarity-sensitive release of free amino acids from cultured kidney cells (MDCK). J. Membr. Biol. 121: 1-9.
53. JESUS, G.J., O.R. SANCHEZ & H. PASANTES-MORALES. 1991. Taurine release associated to volume regulation in rabbit lymphocytes. J. Cell. Biochem. 45: 207-212.
54. MORAN, J., M. SABANERO, I. MEZA & H. PASANTES-MORALES. 1996. Changes of actin cytoskeleton during swelling and regulatory volume decrease in cultured astrocytes Am. J. Physiol. 271: 1901-1907.
55. IDRISS, H.T., Y. A. HANNUN, E. BOULPAEP & S. BASAVAPPA. 2000. Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say! J. Physiol. 524: 629-636.
56. CHEN, L., L. WANG & T.J. JACOB. 1999. Association of intrinsic pICln with volume-activated C1- current and volume regulation in a native epithelial cell. Am. J. Physiol. 276: 182-192.
57. MUSCH, M.W., E.M. DAVIS-AMARAL, H.H. VANDENBURGH & L. GOLDSTEIN. 1998. Hypotonicity stimulates translocation of ICln in neonatal rat cardiac myocytes. Pflugers Arch. 436: 415-422.
58. PAULMICHL, M., Y. LI, K. WICKMAN, et al. 1992. New mammalian chloride channel identified by expression cloning. Nature 356: 238-241.
59. VENNEKENS, R., D. TROUET, A. VANKEERBERGHEN, et al. 1999. Inhibition of volume-regulated anion channels by expression of the cystic fibrosis transmembrane conductance regulator. J. Physiol. 515: 75-85.
60. CHAN, H.C., M.A. KAETZEL, D.J. NELSON, et al. 1992. Antibody against a cystic fibrosis transmembrane conductance regulator-derived synthetic peptide inhibits anion currents in human colonic cell line T84. J. Biol. Chem. 267: 8411-8416.
61. XIA, Y., M.E. KROUSE, R.H. FANG & J.J. WINE. 1996. Swelling and Ca2+-activated anion conductances in C127 epithelial cells expressing WT and delta F508-CFTR. J. Membr. Biol. 151: 269-278.
62. ANDO-AKATSUKA, Y., I.F. ABDULLAEV, E.L. LEE, et al. 2002. Down-regulation of volume-sensitive C1- channels by CFTR is mediated by the second nucleotide-binding domain. Pflugers Arch. 445: 177-186.
63. NILIUS, B. & G. DROOGMANS. 2003. Amazing chloride channels: an overview. Acta Physiol. Scand. 177: 119-147.
64. BOND, T.D., M.A. VALVERDE & C.F. HIGGINS. 1998. Protein kinase C phosphorylation disengages human and mouse-1a P-glycoproteins from influencing the rate of activation of swelling-activated chloride currents. J. Physiol. 508: 333-340.
65. MUNKONGE, P.M., L.R. OSBORNE, D.M. GEDDES & E.W. ALTON. 1994. Lack of inhibition by dideoxy-forskolin and verapamil of DIDS-sensitive volume-activated C1-secretion in human squamous lung carcinoma epithelial cells. Biochim. Biophys. Acta 1224: 342-348.
66. EHRING, G.R., Y.V. OSIPCHUK & M.D. CAHALAN. 1994. Swelling-activated chloride channels in multidrug-sensitive and -resistant cells. J. Gen. Physiol. 104: 1129-1161.
67. VIANA, F., K. VAN ACKER, C. DE GREEF, et al. 1995. Drug-transport and volume-activated chloride channel functions in human erythroleukemia cells: relation to expression level of P-glycoprotein. J. Membr. Biol. 145: 87-98.
68. MIWA, A., K. UEDA & Y. OKADA. 1997. Protein kinase C-independent correlation between P-glycoprotein expression and volume sensitivity of C1- channel. J. Membr. Biol. 157: 63-69.
69. GORG, A., C. OBERMAIER, G. BOGUTH, et al. 2000. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21: 1037-1053.
70. HANASH, S.M. 2000. Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status. Electrophoresis 21: 1202-1209.
71. CZERWENKA, K.F., M. MANAVI, J. HOSMANN, et al. 2001. Comparative analysis of two-dimensional protein patterns in malignant and normal human breast tissue. Cancer Detect. Prev. 25: 268-279.
72. KUERER, H.M., I.L. GOLDKNOPF, H. PRITSCHE, et al. 2002. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery. Cancer 95: 2276-2282.
73. ZHOU, G., H. LI, D. DECAMP, et al. 2002. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics. 1: 117-124.
74. ZHU, H., M. BILGIN & M. SNYDER. 2003. Proteomics. Annu. Rev. Biochem. 72: 783-812.
75. WASHBURN, M.P., D. WOLTERS & J.R. YATES III. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19: 242-247.
76. SCHWEITZER, B., S. ROBERTS, B. GRIMWADE, et al. 2002. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat. Biotechnol. 20: 359-365.
77. HAAB, B.B., M.J. DUNHAM & P.O. BROWN. 2001. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2: 0004.1-0004.13.
78. MERCHANT, M. & S.R. WEINBERGER. 2000. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21: 1164-1177.
79. BAAK, J.P., F.R. PATH, M.A. HERMSEN, et al. 2003. Genomics and proteomics in cancer. Eur. J. Cancer. 39: 1199-1215.
80. COATES, P.J. & P.A. HALL. 2003. The yeast two-hybrid system for identifying protein-protein interactions. J. Pathol. 199: 4-7.
81. VON MERING, C., R. KRAUSE, B. SNEL, et al. 2002. Comparative assessment of large-scale data sets of protein-protein interactions. Nature 417: 399-403.
82. HUSI, H., M.A. WARD, J.S. CHOUDHARY, et al. 2000. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 3: 661-669.
83. YANAGIDA, M. 2002. Functional proteomics; current achievements. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 771: 89-106.
84. BROCKHOFF, G., P. HEISS, J. SCHLEGEL, et al. 2001. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Cytometry 44: 338-348.
85. SEKAR, R.B. & A. PERIASAMY. 2003. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J. Cell Biol. 160: 629-633.
86. WANG, C., R. BOSSE, C. ILLY, et al. 2002. AlphaScreen™. A highly sensitive, nonradioactive and homogeneous assay platform for drug discovery high throughput screening, genomics, and life science research applications in miniaturized format. In Microfabricated Sensors. R. Kordal, A. Usmani & W.T. Law, Eds. ACS Symposium Series 815: 45-56. Oxford University Press.
87. HAYWARD, R.E., G. CAMERON & R.Z. KOZLOWSKI. 2001. Probing the proteome - protein arrays and their applications. Drug Discov. Today 6: 1263-1265.
88. MULDER, M., M. SAMADDAR, J. BOUTELL, et al. 2002. Functional protein arrays. Br. J. Pharmacol. 135: 146P.
89. ZHU, H. & M. SNYDER. 2001. Protein arrays and microarrays. Curr. Opin. Chem. Biol. 5: 40-45.
90. NELSON, R.W., D. NEDELKOV & K.A. TUBBS. 2000. Biosensor chip mass spectrometry: a chip-based proteomics approach. Electrophoresis 21: 1155-1163.
91. ZHU, H., J.F. KLEMIC, S. CHANG, et al. 2000. Analysis of yeast protein kinases using protein chips. Nat. Genet. 26: 283-289.
92. MACBEATH, G. & S.L. SCHREIBER. 2000. Printing proteins as microarrays for high-throughput function determination. Science 289: 1760-1763.
93. ZHU, H., M. BILGIN, R. BANGHAM, et al. 2001. Global analysis of protein activities using proteome chips. Science 293: 2101-2105.
94. PETRICOIN, E.F. & L.A. LIOTTA. 2003. Clinical applications of proteomics. J. Nutr. 133: 2476-2484.
95. ARCHAKOV, A.I., V.M. GOVORUN, A.V. DUBANOV, et al. 2003. Protein-protein interactions as a target for drugs in proteomics. Proteomics 3: 380-391.
96. COCHRAN, A.G. 2001. Protein-protein interfaces: mimics and inhibitors. Curr. Opin. Chem. Biol. 5: 654-659.
97. YOUNG, K., S. LIN, L. SUN, et al. 1998. Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nat. Biotechnol. 16: 946-950.